Definitions
Sorry, no definitions found. You may find more data at otelixizumab.
Etymologies
Sorry, no etymologies found.
Support
Help support Wordnik (and make this page ad-free) by adopting the word Otelixizumab.
Examples
-
Otelixizumab is being developed in collaboration with Glaxo and Tolerx.
Glaxo's BTG Drug Fails to Pass Trial Sten Stovall 2011
-
Tolerx Completes Enrollment in DEFEND-1, A Phase 3 Type 1 Diabetes Study With Otelixizumab today announced the completion of patient enrollment in its Phase 3 clinical study DEFEND-1, which is evaluating the safety
WN.com - Articles related to In memory of Mother: Why are vitamin supplements important part two 2010
-
Tolerx Completes Enrollment in DEFEND-1, A Phase 3 Type 1 Diabetes Study With Otelixizumab today announced the completion of patient enrollment in its Phase 3 clinical study DEFEND-1, which is evaluating the safety
WN.com - Articles related to Exploring the healing power of coconut oil 2010
-
Tolerx Completes Enrollment in DEFEND-1, A Phase 3 Type 1 Diabetes Study With Otelixizumab today announced the completion of patient enrollment in its Phase 3 clinical study DEFEND-1, which is evaluating the safety
WN.com - Articles related to In memory of Mother: Why are vitamin supplements important part two 2010
-
Tolerx Completes Enrollment in DEFEND-1, A Phase 3 Type 1 Diabetes Study With Otelixizumab today announced the completion of patient enrollment in its Phase 3 clinical study DEFEND-1, which is evaluating the safety
WN.com - Articles related to Are your eyes puffy when you wake up in the morning? 2010
-
Tolerx Completes Enrollment in DEFEND-1, A Phase 3 Type 1 Diabetes Study With Otelixizumab today announced the completion of patient enrollment in its Phase 3 clinical study DEFEND-1, which is evaluating the safety
WN.com - Articles related to New technique shakes brain cancer cells to death 2010
-
Tolerx Completes Enrollment in DEFEND-1, A Phase 3 Type 1 Diabetes Study With Otelixizumab today announced the completion of patient enrollment in its Phase 3 clinical study DEFEND-1, which is evaluating the safety
WN.com - Articles related to Biological Clocks Control Cell Division in Bacteria 2010
-
Tolerx Completes Enrollment in DEFEND-1, A Phase 3 Type 1 Diabetes Study With Otelixizumab today announced the completion of patient enrollment in its Phase 3 clinical study DEFEND-1, which is evaluating the safety
-
Tolerx Completes Enrollment in DEFEND-1, A Phase 3 Type 1 Diabetes Study With Otelixizumab today announced the completion of patient enrollment in its Phase 3 clinical study DEFEND-1, which is evaluating the safety
WN.com - Articles related to New technique shakes brain cancer cells to death 2010
-
Tolerx Completes Enrollment in DEFEND-1, A Phase 3 Type 1 Diabetes Study With Otelixizumab today announced the completion of patient enrollment in its Phase 3 clinical study DEFEND-1, which is evaluating the safety
Comments
Log in or sign up to get involved in the conversation. It's quick and easy.